Additionally, AREG produced by FOXP3+Tregs can facilitate the repair of alveolar epithelial cells damaged by COVID-19 infection while maintaining blood oxygen saturation levels in ARDS patients during later stages of the disease. Here, FOXP3 is linked to acute respiratory distress syndrome.